The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas

Elena Binda, Alberto Visioli, Fabrizio Giani, Giuseppe Lamorte, Massimiliano Copetti, Ken L. Pitter, Jason T. Huse, Laura Cajola, Nadia Zanetti, Francesco DiMeco, Lidia De Filippis, Annunziato Mangiola, Giulio Maira, Carmelo Anile, Pasquale De Bonis, Brent A. Reynolds, Elena B. Pasquale, Angelo L. Vescovi

Research output: Contribution to journalArticle

Abstract

In human glioblastomas (hGBMs), tumor-propagating cells with stem-like characteristics (TPCs) represent a key therapeutic target. We found that the EphA2 receptor tyrosine kinase is overexpressed in hGBM TPCs. Cytofluorimetric sorting into EphA2High and EphA2Low populations demonstrated that EphA2 expression correlates with the size and tumor-propagating ability of the TPC pool in hGBMs. Both ephrinA1-Fc, which caused EphA2 downregulation in TPCs, and siRNA-mediated knockdown of EPHA2 expression suppressed TPCs self-renewal ex vivo and intracranial tumorigenicity, pointing to EphA2 downregulation as a causal event in the loss of TPCs tumorigenicity. Infusion of ephrinA1-Fc into intracranial xenografts elicited strong tumor-suppressing effects, suggestive of therapeutic applications.

Original languageEnglish
Pages (from-to)765-780
Number of pages16
JournalCancer Cell
Volume22
Issue number6
DOIs
Publication statusPublished - Dec 11 2012

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Fingerprint Dive into the research topics of 'The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas'. Together they form a unique fingerprint.

Cite this